AMANDA SHIRLEY: Open Payments
NPI 1689235806 · BURLINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 75 payments from 19 companies in 2025. Trend: 2023 $2,038 · 2024 $1,609 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 36 | $449 |
| Corcept Therapeutics | 3 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70 |
| Esperion Therapeutics, Inc. | 3 | $66 |
| Merck Sharp & Dohme LLC | 4 | $65 |
| ABBVIE INC. | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Viatris Specialty LLC | 2 | $35 |
Products named: Wegovy, Ozempic, Korlym, CAPLYTA, JARDIANCE, NEXLETOL, VERQUVO, REXULTI.
Industry payments across NC — which companies pay providers there.
